Adverse Market Change Sample Clauses

Adverse Market Change. After the date hereof and prior to the Closing Date, there shall not have occurred a suspension or material limitation in trading in Buyer's securities on NASDAQ which occurrence is still outstanding as of the Closing Date, if the effect of any such event in the reasonable judgment of the Company makes it impracticable or inadvisable to proceed with the transactions contemplated in this Agreement and the Ancillary Documents.
Sample 1Sample 2See All (8)
AutoNDA by SimpleDocs
Adverse Market Change. Since June 30, 2001 no material adverse change shall have occurred in the syndication markets for credit facilities similar in nature to this Agreement and no material disruption of or material adverse change in the financial, banking or capital markets that would have an adverse effect on such syndication market shall have occurred, in each case as determined by the Agent and the Co-Arrangers in their sole discretion.
Sample 1See All (8)
Adverse Market Change. On or after the date hereof and prior to the Determination Date, there shall not have occurred any of the following: (A) a suspension or material limitation in trading in securities generally on the Nasdaq National Market, the New York Stock Exchange or the London Stock Exchange, (B) a suspension or material limitation in trading in Buyer's securities on the Nasdaq National Market, (C) a general moratorium on commercial banking activities in New York, London, the PRC or the Cayman Islands declared by the relevant authorities, or a material disruption in commercial banking or securities settlement or clearance services in the United States, the United Kingdom, the PRC or the Cayman Islands, (D) the outbreak or escalation of hostilities involving the United States, the United Kingdom the PRC or the Cayman Islands or the declaration by the United States, the United Kingdom, the PRC or the Cayman Islands of a national emergency or war or (E) the occurrence of any other calamity or crisis or any change in financial, political or economic conditions or currency exchange rates or controls in the United States, the United Kingdom, the PRC, the Cayman Islands or elsewhere, if the effect of any such event specified in clause (D) or (E) in the judgment of Buyer makes it impracticable or inadvisable to proceed with the transaction contemplated in this Agreement and the Ancillary Documents.
Sample 1Sample 2
Adverse Market Change. Since December 31, 199$ no material adverse change shall have occurred in the financial condition or operations of the Borrower.
Sample 1
Adverse Market Change. Since December 31, 1998, no material adverse change has occurred in the financial condition or operations of the Borrower or Candlewood (provided, however, that notwithstanding anything else herein to the contrary, the representation as to Candlewood is made only as of the date hereof and as of the date of the initial advance of the Loan and not as of any subsequent date).
Sample 1
Adverse Market Change. Notwithstanding anything herein contained, if after the execution of this Agreement there shall come to the attention of the Lender such a change in national or international monetary, financial, political, economic or stock market conditions or currency exchange or interest rates or exchange controls as would, in the reasonable opinion of the Lender, be likely to prejudice materially the success of the Facility, the Lender may terminate this Agreement and upon such notice being given the parties hereto shall (except as otherwise specifically provided herein) be released and discharged from their respective obligations under this Agreement.
Sample 1
Adverse Market Change. 43 5.1.10. Acquisition 43 5.1.11. Year 2000 Plan. 44 5.1.12. Pro forma Compliance 44 5.1.13. Subordinated Debentures 45 5.2. Conditions to Each Extension of Credit 45 5.2.1. Officer's Certificate 45 5.2.2. Proper Proceedings 45 5.2.3. Legality, etc 45 5.2.4. General 46
Sample 1
AutoNDA by SimpleDocs
Adverse Market Change. If, in either Party’s reasonable discretion, a Party observes potential Adverse Market Changes that may impact the marketing and sale of Sasol Product, either Party may request a consultation regarding potential revisions to the then-current Annual Marketing Plan. If Sasol Member is the requesting Party, Marketer shall be obligated to (whether by telecommunication, videoconference or in person), within ten (10) Business Days of Sasol Member’s notice, meet and consult with Sasol Member to discuss any necessary updates to the then-current the Annual Marketing Plan. If Marketer is the requesting Party, after Sasol Member receives Marketer’s notice for consultation, Sasol Member shall notify Marketer within ten (10) Business Days if Sasol Member desires to consult with Marketer regarding any necessary updates to the then-current Annual Marketing Plan and Marketer shall (whether by telecommunication, videoconference or in person), within ten (10) Business Days of Sasol Member’s notice, meet and consult with Sasol Member to discuss such updates to the then- current Annual Marketing Plan. If Marketer and Sasol Member agree on the proposed updated Annual Marketing Plan, Marketer shall make all agreed-upon updates and issue the updated Annual Marketing Plan so agreed, and such updated Annual Marketing Plan shall be deemed the Annual Marketing Plan for the remainder of the applicable Fiscal Year for all purposes hereunder. If (i) Sasol Member chooses not to consult with Marketer or (ii) the Parties are unable to agree on all proposed updates to the Annual Marketing Plan, after the Parties have escalated the matter to the senior executives of the ultimate parents of both Parties for consultation (which senior executives, for purposes of clarity, shall be Persons with no lower level of seniority than
Sample 1

Related to Adverse Market Change

  • Adverse Selection No selection procedures adverse to the Noteholders or the Insurer were utilized in selecting the Receivables from those receivables owned by the Seller which met the selection criteria contained in the Sale and Servicing Agreement.

  • No Material Adverse Change or Ratings Agency Change For the period from and after the date of this Agreement and prior to the Closing Date:

  • No Material Adverse Effect or Ratings Agency Change For the period from and after the date of this Agreement and prior to the Closing Date:

  • Internal Control Over Financial Reporting The Company and each of its Subsidiaries maintain a system of internal control over financial reporting (as such term is defined in Rule 13a-15(f) of the Exchange Act Regulations) that complies with the requirements of the Exchange Act and the Exchange Act Regulations and has been designed by the Company’s principal executive officer and principal financial officer and is sufficient to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including that (A) transactions are executed in accordance with management’s general or specific authorizations; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (C) access to assets is permitted only in accordance with management’s general or specific authorization; (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (E) the interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement is accurate and fairly presents the information called for in all material respects and has been prepared in accordance with the Commission’s rules and guidelines applicable thereto. The systems of internal control over financial reporting of the Company and its Subsidiaries are overseen by the Audit Committee of the Board of Directors of the Company in accordance with Nasdaq rules and regulations. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, since the end of the Company’s most recent audited fiscal year, (i) there has been no material weakness in the Company’s internal control over financial reporting (whether or not remediated), (ii) there has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting and (iii) the Company has not been advised of (a) any significant deficiencies in the design or operation of internal controls that could adversely affect the ability of the Company or any Subsidiary to record, process, summarize and report financial data, or any material weakness in internal controls, or (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the internal controls of the Company and each of the Subsidiaries.

  • Adverse Event Reporting Both Parties acknowledge the obligation to comply with the Protocol and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

  • Internal Control Effective control and accountability must be maintained for all cash, real and personal property, and other assets. Grantee must adequately safeguard all such property and must provide assurance that it is used solely for authorized purposes. Grantee must also have systems in place that provide reasonable assurance that the information is accurate, allowable, and compliant with the terms and conditions of this Agreement. 2 CFR 200.303.

  • PRINCIPAL MARKET REGULATION The Company shall not issue any Put Shares, and the Investor shall not have the right to receive any Put Shares, if the issuance of such shares would exceed the Exchange Cap.

  • Statistical or Market-Related Data Any statistical, industry-related and market-related data included or incorporated by reference in the Time of Sale Disclosure Package, are based on or derived from sources that the Company reasonably and in good faith believes to be reliable and accurate, and such data agree with the sources from which they are derived.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!